Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 21, 2014
TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methodsBarbara Kantorova, Jitka Malcikova, Jana Smardova, et al.
Blood|January 12, 2012
MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemiaMarek Mraz, Dasa Dolezalova, Karla Plevova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic LeukemiaPavlina Janovska, Lucie Poppova, Karla Plevova, et al.
British Journal of Haematology|September 22, 2016
Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHVLucie Poppova, Pavlina Janovska, Karla Plevova, et al.
American Journal of Hematology|October 30, 2013
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic dataPanagiotis Baliakas, Michalis Iskas, Anne Gardiner, et al.
Cell Reports|October 21, 2023
Cerebral organoids derived from patients with Alzheimer's disease with PSEN1/2 mutations have defective tissue patterning and altered developmentTereza Vanova, Jiri Sedmik, Jan Raska, et al.
Epigenetics|March 25, 2022
Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A geneLucie Poppova, Sarka Pavlova, Beatriz Gonzalez, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 28, 2019
Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national studyKamila Stranska, Karla Plevova, Hana Skuhrova Francova, et al.
Blood|May 4, 2021
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment optionsJitka Malcikova, Sarka Pavlova, Barbara Kunt Vonkova, et al.
Blood|January 11, 2018
Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemiaPavlina Janovska, Jan Verner, Jiri Kohoutek, et al.
Pageof 6